Patient Similarity Networks for Precision Medicine
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Clinical research and practice in the 21st century is poised to be transformed by analysis of computable electronic medical records and population-level genome-scale patient profiles. Genomic data capture genetic and environmental state, providing information on heterogeneity in disease and treatment outcome, but genomic-based clinical risk scores are limited. Achieving the goal of routine precision medicine that takes advantage of these rich genomics data will require computational methods that support heterogeneous data, have excellent predictive performance, and ideally, provide biologically interpretable results. Traditional machine-learning approaches excel at performance, but often have limited interpretability. Patient similarity networks are an emerging paradigm for precision medicine, in which patients are clustered or classified based on their similarities in various features, including genomic profiles. This strategy is analogous to standard medical diagnosis, has excellent performance, is interpretable, and can preserve patient privacy. We review new methods based on patient similarity networks, including Similarity Network Fusion for patient clustering and netDx for patient classification. While these methods are already useful, much work is required to improve their scalability for contemporary genetic cohorts, optimize parameters, and incorporate a wide range of genomics and clinical data. The coming 5 years will provide an opportunity to assess the utility of network-based algorithms for precision medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728 · cited 1×
“The UK BioBank is a similar initiative supported by multiple government and not-for-profit agencies in the UK 29 .”
BackgroundComprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
The Ensembl Variant Effect Predictor
McLaren, W., Gil, L., Hunt, S. E., Riat, H. S., Ritchie, G. R. S., Thormann, A., Flicek, P., & Cunningham, F. (2016) · Genome Biology · doi:10.1186/s13059-016-0974-4 · Cited by 8,099
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
Topological domains in mammalian genomes identified by analysis of chromatin interactions
Dixon, J. R., Selvaraj, S., Yue, F., Kim, A., Li, Y., Shen, Y., Hu, M., Liu, J. S., & Ren, B. (2012) · Nature · doi:10.1038/nature11082 · Cited by 6,829 · cited 1×
“New information about chromatin structure is also being mapped, such as topological associated domains (or TADs), characterized by high within-region chromatin looping, relative to interactions outside the region 82,83 , and enhancer-promoter loops that activate transcription.”
BackgroundThe Reactome pathway Knowledgebase
Fabregat, A., Sidiropoulos, K., Garapati, P., Gillespie, M., Hausmann, K., Haw, R., Jassal, B., Jupe, S., Korninger, F., McKay, S., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1351 · Cited by 5,605
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170 · cited 1×
“…3) automate ways to generally improve signal-to-noise ratio; 4) automate ways to characterize patient heterogeneity, like disease subtypes 26,51,66,75 ; 5) make the best use of complementary genomics layers which may have complex relationships (e.g. gene expression is modulated by genetic…”
MethodCommon polygenic variation contributes to risk of schizophrenia and bipolar disorder
The International Schizophrenia Consortium (2009) · Nature · doi:10.1038/nature08185 · Cited by 4,821 · cited 3×
“A polygenic risk score is typically used to model these weak contributions, where an individual’s genetic risk is the sum of all the risk alleles carried by that individual, weighted by the significance of the corresponding allele in a GWAS study 23,38–40 .”
BackgroundMethodInfluentialGenetic effects on gene expression across human tissues
GTEx Consortium (2017) · Nature · doi:10.1038/nature24277 · Cited by 4,036
Hindorff, L. A., Sethupathy, P., Junkins, H. A., Ramos, E. M., Mehta, J. P., Collins, F. S., & Manolio, T. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903103106 · Cited by 4,013 · cited 1×
“Given that 43% of disease-associated genetic variants are located in intergenic regions (88% lie in noncoding regions, which includes introns) 81 , incorporating non-coding and epigenetic information about gene regulation is important for a model seeking to explain clinical outcome.”
BackgroundComprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Spatial partitioning of the regulatory landscape of the X-inactivation centre
Nora, E. P., Lajoie, B. R., Schulz, E. G., Giorgetti, L., Okamoto, I., Servant, N., Piolot, T., van Berkum, N. L., Meisig, J., Sedat, J., et al. (2012) · Nature · doi:10.1038/nature11049 · Cited by 2,895 · cited 1×
“New information about chromatin structure is also being mapped, such as topological associated domains (or TADs), characterized by high within-region chromatin looping, relative to interactions outside the region 82,83 , and enhancer-promoter loops that activate transcription.”
BackgroundEnrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation
Merico, D., Isserlin, R., Stueker, O., Emili, A., & Bader, G. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013984 · Cited by 2,235 · cited 1×
“Pathway definitions were aggregated from HumanCyc 67 IOB’s NetPath 68 , Reactome 69,70 , NCI Curated Pathways 71 , mSigDB 72 , and Panther 73 (http://download.baderlab.org/ EM_Genesets/February_01_2018/Human/symbol/ Human_AllPathways_February_01_2018_symbol.gmt) 74 .”
MethodSelf-citationThe new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog)
MacArthur, J., Bowler, E., Cerezo, M., Gil, L., Hall, P., Hastings, E., Junkins, H., McMahon, A., Milano, A., Morales, J., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1133 · Cited by 2,161
Epidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148 · cited 1×
“The ASCVD is the result of five decades of model development, with its roots in the Framingham Heart Study of the 1950’s 3,4 .”
BackgroundSimilarity network fusion for aggregating data types on a genomic scale
Wang, B., Mezlini, A. M., Demir, F., Fiume, M., Tu, Z., Brudno, M., Haibe-Kains, B., & Goldenberg, A. (2014) · Nature Methods · doi:10.1038/nmeth.2810 · Cited by 2,036
Integrated genomic characterization of pancreatic ductal adenocarcinoma
Raphael, B. J., Hruban, R. H., Aguirre, A. J., Moffitt, R. A., Yeh, J. J., Stewart, C., Robertson, A. G., Cherniack, A. D., Gupta, M., Getz, G., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.007 · Cited by 2,019
Large-scale association analysis identifies new risk loci for coronary artery disease
The CARDIoGRAMplusC4D Consortium, Deloukas, P., DIAGRAM Consortium, CARDIOGENICS Consortium, MuTHER Consortium, Wellcome Trust Case Control Consortium, Kanoni, S., Willenborg, C., Farrall, M., Assimes, T. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2480 · Cited by 1,614 · cited 1×
“…in Alzheimer’s disease 17,18 ; 6.7X risk increase for BRCA1/2 mutations in breast cancer; 6–17X for HLAII alleles in familial type 1 diabetes 19 ) and which diseases have smaller, polygenic contributions (1.10–1.20 for schizophrenia 20 , coronary artery disease 21 , and bipolar disorder 22,23 ).”
BackgroundInfluentialPID: the Pathway Interaction Database
Schaefer, C. F., Anthony, K., Krupa, S., Buchoff, J., Day, M., Hannay, T., & Buetow, K. H. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn653 · Cited by 1,603
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
Hippisley-Cox, J., Coupland, C., Vinogradova, Y., Robson, J., Minhas, R., Sheikh, A., & Brindle, P. (2008) · BMJ · doi:10.1136/bmj.39609.449676.25 · Cited by 1,459
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C. R., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.06.003 · Cited by 1,233
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Cavalli, F. M. G., Remke, M., Rampasek, L., Peacock, J., Shih, D. J. H., Luu, B., Garzia, L., Torchia, J., Nor, C., Morrissy, A. S., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.005 · Cited by 1,219
Self-citationMillion Veteran Program: A mega-biobank to study genetic influences on health and disease
Gaziano, J. M., Concato, J., Brophy, M., Fiore, L., Pyarajan, S., Breeling, J., Whitbourne, S., Deen, J., Shannon, C., Humphries, D., et al. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.09.016 · Cited by 1,055
A multivariate analysis of the risk of coronary heart disease in Framingham
Truett, J., Cornfield, J., & Kannel, W. (1967) · Journal of Chronic Diseases · doi:10.1016/0021-9681(67)90082-3 · Cited by 958 · cited 1×
“The ASCVD is the result of five decades of model development, with its roots in the Framingham Heart Study of the 1950’s 3,4 .”
BackgroundApolipoprotein E in Alzheimer’s disease and other neurological disorders
Verghese, P. B., Castellano, J. M., & Holtzman, D. M. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70325-2 · Cited by 857 · cited 1×
“…; this research has identified which diseases have a few big risk-effect variants (3X risk increase for each APOe4 allele in Alzheimer’s disease 17,18 ; 6.7X risk increase for BRCA1/2 mutations in breast cancer; 6–17X for HLAII alleles in familial type 1 diabetes 19 ) and which diseases have…”
BackgroundThe Simons Simplex Collection: a resource for identification of autism genetic risk factors
Fischbach, G. D., & Lord, C. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.006 · Cited by 725
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
Mack, S. C., Witt, H., Piro, R. M., Gu, L., Zuyderduyn, S., Stütz, A. M., Wang, X., Gallo, M., Garzia, L., Zayne, K., et al. (2014) · Nature · doi:10.1038/nature13108 · Cited by 607 · cited 2×
“…features; 3) automate ways to generally improve signal-to-noise ratio; 4) automate ways to characterize patient heterogeneity, like disease subtypes 26,51,66,75 ; 5) make the best use of complementary genomics layers which may have complex relationships (e.g. gene expression is modulated by…”
BackgroundMethodSelf-citationRipatti, S., Tikkanen, E., Orho-Melander, M., Havulinna, A. S., Silander, K., Sharma, A., Guiducci, C., Perola, M., Jula, A., Sinisalo, J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61267-6 · Cited by 562
Clarke, T.-K., Adams, M. J., Davies, G., Howard, D. M., Hall, L. S., Padmanabhan, S., Murray, A. D., Smith, B. H., Campbell, A., Hayward, C., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.153 · Cited by 440
Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?
MEYER, U., FELDON, J., & DAMMANN, O. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e318212c196 · Cited by 357 · cited 1×
“An early example is the use of improved phenotyping in 1971 to recognize that autism spectrum disorder was a different disease than schizophrenia 2 .”
BackgroundHu, Y., Shmygelska, A., Tran, D., Eriksson, N., Tung, J. Y., & Hinds, D. A. (2016) · Nature Communications · doi:10.1038/ncomms10448 · Cited by 321
Franzén, O., Ermel, R., Cohain, A., Akers, N. K., Di Narzo, A., Talukdar, H. A., Foroughi-Asl, H., Giambartolomei, C., Fullard, J. F., Sukhavasi, K., et al. (2016) · Science · doi:10.1126/science.aad6970 · Cited by 288 · cited 1×
“At the other end of the spectrum are highly polygenic disorders, where hundreds of common variants contribute small effects to disease risk; these include cardiovascular disease, schizophrenia and bipolar disorder 22,23,34,36,37 .”
BackgroundA critical assessment of Mus musculusgene function prediction using integrated genomic evidence
Peña-Castillo, L., Tasan, M., Myers, C. L., Lee, H., Joshi, T., Zhang, C., Guan, Y., Leone, M., Pagnani, A., Kim, W. K., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-s1-s2 · Cited by 248
Compact integration of multi-network topology for functional analysis of genes
Cho, H., Berger, B., & Peng, J. (2016) · Cell Systems · doi:10.1016/j.cels.2016.10.017 · Cited by 241
Polygenic score prediction captures nearly all common genetic risk for Alzheimer's disease
Escott-Price, V., Shoai, M., Pither, R., Williams, J., & Hardy, J. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.07.018 · Cited by 183
the 23andMe Research Team, Sanchez-Roige, S., Fontanillas, P., Elson, S. L., Pandit, A., Schmidt, E. M., Foerster, J. R., Abecasis, G. R., Gray, J. C., de Wit, H., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-017-0032-x · Cited by 128 · cited 1×
“Private-sector projects include the AstraZeneca bid to sequence two million genomes to identify rare genetic variants that affect drug response 30 , and the repository of the direct-to-consumer genetic testing service, 23andMe Inc., which are now being used for focused GWAS 31,32 .”
BackgroundPolygenic Scores for Major Depressive Disorder and Risk of Alcohol Dependence
Andersen, A. M., Pietrzak, R. H., Kranzler, H. R., Ma, L., Zhou, H., Liu, X., Kramer, J., Kuperman, S., Edenberg, H. J., Nurnberger, J. I., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.2269 · Cited by 90
Cited by
Zitnik, M., Nguyen, F., Wang, B., Leskovec, J., Goldenberg, A., & Hoffman, M. M. (2019) · Information Fusion · doi:10.1016/j.inffus.2018.09.012 · Cited by 675
Bashir, A. K., Victor, N., Bhattacharya, S., Huynh-The, T., Chengoden, R., Yenduri, G., Maddikunta, P. K. R., Pham, Q.-V., Gadekallu, T. R., & Liyanage, M. (2023) · IEEE Internet of Things Journal · doi:10.1109/jiot.2023.3304790 · Cited by 183
“Such data can be used for finding patient similarity [59], remote patient monitoring [60], and for predicting mortality rates.”
BackgroundPatient Similarity Learning with Selective Forgetting
Qian, W., Zhao, C., Shao, H., Chen, M., Wang, F., & Huai, M. (2022) · 2022 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm55620.2022.9995016 · Cited by 11
Multimorbidity Measurement Strategies for Predicting Hospital Visits
Neves, B., Moreira, J. M., Gonçalves, S., Cerejo, J., Mota, I., Silva, N. A., Leite, F., & Silva, M. J. (2025) · doi:10.21203/rs.3.rs-6515465/v1
Metadata
- Authors
- Pai, S., & Bader, G. D.
- Venue
- Journal of Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 430
- Issue
- 18
- Pages
- 2924-2938
- ISSN
- 0022-2836 (ISSN-L)
- OpenAlex
- W2807280338
- Cited by
- 154
- References
- 40
- FWCI
- 8.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.